The effect of topical anesthesia on the rat electroretinogram

Documenta Ophthalmologica

Volumn 118, Issue 2, 2009, Pages 101-108

  Sandalon, Shai ^a   Ofri, Ron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Action potential; Full field ERG; Oxybuprocaine; Pattern ERG; Voltage gated sodium channel

Indexed keywords

LOCAL ANESTHETIC AGENT; LOCALIN; OXYBUPROCAINE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; B WAVE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRORETINOGRAM; NIGHT VISION; NONHUMAN; PHOTOPIC VISION; RANDOMIZATION; RAT; TOPICAL ANESTHESIA;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ANIMALS; ELECTRODES; ELECTRORETINOGRAPHY; PROCAINE; RATS; RATS, INBRED LEW; RETINA; TIME FACTORS;

EID: 61849101830     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-008-9141-x     Document Type: Article

References (26)

1. Marmor MF, Holder GE, Seeliger MW, Yamamoto S (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107-114. doi: 10.1023/B:DOOP.0000036793.44912.45
2. Parkinson J, Tremblay F (2008) Obtaining a contact lens acquired electroretinogram in the presence of topical anesthetic hypersensitivity. Doc Ophthalmol 116:245-249
3. Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M (2007) ISCEV standard for clinical pattern electroretinography (2007 update). Doc Ophthalmol 114:111-116. doi: 10.1007/s10633-007-9053-1
4. Holder GE (2006) The pattern electroretinogram. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. The MIT Press, Cambridge/London, pp 341-352
5. Arden GB, Hogg CR, Holder GE (1994) Gold foil electrodes: A two-center study of electrode reliability. Doc Ophthalmol 86:275-284. doi: 10.1007/ BF01203551
6. Wilson G, Fullard RJ (1988) Cell sloughing with proparacaine. J Am Optom Assoc 59:701-702
7. Penna EP, Tabbara KF (1986) Oxybuprocaine keratopathy: A preventable disease. Br J Ophthalmol 70:202-204. doi: 10.1136/bjo.70.3.202
8. Asensio I, Rahhal SM, Alonso L, Palanca-Sanfrancisco JM, Sanchis-Gimeno JA (2003) Corneal thickness values before and after oxybuprocaine 0.4% eye drops. Cornea 22:527-532. doi: 10.1097/00003226-200308000-00008
9. Nam SM, Lee HK, Kim EK, Seo KY (2006) Comparison of corneal thickness after the instillation of topical anesthetics: Proparacaine versus oxybuprocaine. Cornea 25:51-54. doi: 10.1097/01.ico.0000179929.97651.59
10. Mojumder DK, Frishman LJ, Otteson DC, Sherry DM (2007) Voltage-gated sodium channel alpha-subunits Na(v)1.1, Na(v)1.2, and Na(v)1.6 in the distal mammalian retina. Mol Vis 13:2163-2182
11. Kawai F, Horiguchi M, Suzuki H, Miyachi E (2001) Na(+) action potentials in human photoreceptors. Neuron 30:451-458. doi: 10.1016/ S0896-6273(01)00299-9
12. Brown KT, Wiesel TN (1961) Localization of origins of electroretinogram components by intraretinal recording in the intact cat eye. J Physiol 158:257-280
13. Liang C, Peyman GA, Sun G (1998) Toxicity of intraocular lidocaine and bupivacaine. Am J Ophthalmol 125:191-196. doi: 10.1016/ S0002-9394(99)80091-9
14. Lincoff H, Zweifach P, Brodie S, Fuchs W, Gross S, Kornmehl E et al (1985) Intraocular injection of lidocaine. Ophthalmology 92:1587-1591
15. Anders N, Heuermann T, Rüther K, Hartmann C (1999) Clinical and electrophysiologic results after intracameral lidocaine 1% anesthesia: A prospective randomized study. Ophthalmology 106:1863-1868. doi: 10.1016/ S0161-6420(99)90394-9
16. Kuhlmann O, Stoldt G, Struck HG, Krauss GJ (1998) Simultaneous determination of diclofenac and oxybuprocaine in human aqueous humor with HPLC and electrochemical detection. J Pharm Biomed Anal 17:1351-1356. doi: 10.1016/S0731-7085(98)00009-0
17. Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I (1999) Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 40:3160-3167
18. Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y et al (2001) Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Invest Ophthalmol Vis Sci 42:2589-2595
19. Layton CJ, Chidlow G, Casson RJ, Wood JP, Graham M, Osborne NN (2005) Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat. Invest Ophthalmol Vis Sci 46:2878-2885. doi: 10.1167/iovs.04-1458
20. Ben-Shlomo G, Bakalash S, Lambrou GN, Latour E, Dawson WW, Schwartz M et al (2005) Pattern electroretinography in a rat model of ocular hypertension: Functional evidence for early detection of inner retinal damage. Exp Eye Res 81:340-349
21. Gouras P, Niemeyer G (1973) Rod and cone signals in S-potentials of the isolated perfused cat eye. Vision Res 13:1603-1612. doi: 10.1016/ 0042-6989(73)90017-5
22. van Wart A, Boiko T, Trimmer JS, Matthews G (2005) Novel clustering of sodium channel Na(v)1.1 with ankyrin-G and neurofascin at discrete sites in the inner plexiform layer of the retina. Mol Cell Neurosci 28:661-673. doi: 10.1016/j.mcn.2004.11.012
23. Lipton SA, Tauck DL (1987) Voltage-dependent conductances of solitary ganglion cells dissociated from the rat retina. J Physiol 385:361-391
24. Pan ZH, Hu HJ (2000) Voltage-dependent Na(+) currents in mammalian retinal cone bipolar cells. J Neurophysiol 84:2564-2571
25. Kasuya F, Igarashi K, Fukui M (1987) Metabolism of benoxinate in humans. J Pharm Sci 76:303-305. doi: 10.1002/jps.2600760408
26. Sánchez-Chávez G, Salceda R (2001) Acetyl- and butyrylcholinesterase in normal and diabetic rat retina. Neurochem Res 26:153-159. doi: 10.1023/A:1011098829378